Efficacy of first-line systemic therapy for left-sided primary metastatic colon cancer: a single-centre retrospective cohort analysis of 186 patients

被引：0
|
作者：
Prejac, J. [1 ]
Kekez, D. [2 ]
Belev, B. [3 ]
Plestina, S. [3 ]
机构：
[1] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Dent Med, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 226
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancer
    Wong, W. W. L.
    Zargar, M.
    Berry, S. R.
    Ko, Y. J.
    Riesco-Martinez, M.
    Chan, K. K. W.
    CURRENT ONCOLOGY, 2019, 26 (05) : E597 - E609
  • [22] Synchronous metastatic colon cancer and the importance of primary tumor laterality-A National Cancer Database analysis of right-versus left-sided colon cancer
    Zhao, Beiqun
    Lopez, Nicole E.
    Eisenstein, Samuel
    Schnickel, Gabriel T.
    Sicklick, Jason K.
    Ramamoorthy, Sonia L.
    Clary, Bryan M.
    AMERICAN JOURNAL OF SURGERY, 2020, 220 (02): : 408 - 414
  • [23] Response rate and survival for patients with metastatic colorectal cancer from right-sided versus left-sided tumors, treated with first-line triplet chemotherapy with bevacizumab.
    Bazarbashi, Shouki
    Omar, Ayman
    Aljubran, Ali Husain
    Alzahrani, Ahmed M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [24] The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
    Kun-Han Lee
    Wei-Shone Chen
    Jeng-Kai Jiang
    Shung-Haur Yang
    Huann-Sheng Wang
    Shih-Ching Chang
    Yuan-Tzu Lan
    Chun-Chi Lin
    Hung-Hsin Lin
    Sheng-Chieh Huang
    Hou-Hsuan Cheng
    Yee Chao
    Hao-Wei Teng
    British Journal of Cancer, 2021, 125 : 816 - 825
  • [25] The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
    Lee, Kun-Han
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Yang, Shung-Haur
    Wang, Huann-Sheng
    Chang, Shih-Ching
    Lan, Yuan-Tzu
    Lin, Chun-Chi
    Lin, Hung-Hsin
    Huang, Sheng-Chieh
    Cheng, Hou-Hsuan
    Chao, Yee
    Teng, Hao-Wei
    BRITISH JOURNAL OF CANCER, 2021, 125 (06) : 816 - 825
  • [26] Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study
    Martinelli, Giovanni
    Montoro, Juan
    Vanazzi, Anna
    Andreola, Giovanna
    Liptrott, Sarah
    Radice, Davide
    Negri, Mara
    Preda, Lorenzo
    Pruneri, Giancarlo
    Laszlo, Daniele
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (04) : 129 - 135
  • [27] The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy
    Cai, Changjing
    Luo, Qingqing
    Liu, Yihan
    Peng, Yinghui
    Zhang, Xiangyang
    Jiang, Zhaohui
    Feng, Ziyang
    Qi, Yaru
    Gao, Yan
    Liu, Yongting
    Liu, Ping
    Chen, Yihong
    Guo, Cao
    Shen, Hong
    Zeng, Shan
    Han, Ying
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis
    Aboudaram, Amelie
    Chaltiel, Leonor
    Pouessel, Damien
    Graff-Cailleaud, Pierre
    Benziane-Ouaritini, Nicolas
    Sargos, Paul
    Schick, Ulrike
    Crehange, Gilles
    Moyal, Elizabeth Cohen-Jonathan
    Chevreau, Christine
    Khalifa, Jonathan
    CANCERS, 2023, 15 (04)
  • [29] Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis
    Nadia Bianco
    Monica Milano
    Eleonora Pagan
    Chiara Oriecuia
    Vincenzo Bagnardi
    Elena Guerini Rocco
    Giorgia Irene Santomauro
    Giulia Peruzzotti
    Marco Colleoni
    Giuseppe Viale
    Breast Cancer Research and Treatment, 2022, 191 : 137 - 145
  • [30] Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis
    Bianco, Nadia
    Milano, Monica
    Pagan, Eleonora
    Oriecuia, Chiara
    Bagnardi, Vincenzo
    Rocco, Elena Guerini
    Santomauro, Giorgia Irene
    Peruzzotti, Giulia
    Colleoni, Marco
    Viale, Giuseppe
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (01) : 137 - 145
12345